Stake sale
Unicorn India Ventures partly exits Sascan Meditech
By Abha Lohia · Editor ·
Unicorn India Ventures: funding and every story →
Mumbai
- The fund sold part of its holding in Thiruvananthapuram cancer-screening maker Sascan Meditech, earning about six times its money on the exit
- It had put ₹2 crore into the company across two rounds, first in 2020 as its earliest institutional backer, then again in 2021
- The fund keeps a sizeable stake, and Sascan's products include OralScan for oral cancer screening and CerviScan for cervical examination
What happened
- Unicorn India Ventures made a partial exit (selling part of its stake) from Sascan Meditech.
- The exit returned about 6x the money to the fund.
- It had invested ₹2 crore over two rounds, in 2020 and 2021.
- The fund still holds a substantial stake in the company.
- Sascan was founded in 2015 by laser scientist Dr Subhash Narayanan.
Terms in this story
- Unicorn: A unicorn is a privately held startup valued at $1 billion or more, roughly ₹8,000 to ₹9,000 crore as of November 2026. India's count depends on who counts: Tracxn listed 131 in May 2026, while the Hurun Global Unicorn Index named 61 in June 2026, ranking India fourth in the world.
- Unicorn: A unicorn is a private startup valued at $1 billion or more, and a decacorn is valued at $10 billion or more. A soonicorn is an informal label for a company that looks close to the first line, roughly $500 million to $1 billion. These are labels, not legal categories.
Read next
Everything on Unicorn India Ventures → · All startup news on 17 July 2024 →
Is this Unicorn India Ventures? Get your “Featured on StopDown” badge →